| An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases DE Griffith, T Aksamit, BA Brown-Elliott, A Catanzaro, C Daley, F Gordin, ... American journal of respiratory and critical care medicine 175 (4), 367-416, 2007 | 6363 | 2007 |
| SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14, 2020 | 1614 | 2020 |
| Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline CL Daley, JM Iaccarino, C Lange, E Cambau, RJ Wallace Jr, C Andrejak, ... Clinical Infectious Diseases 71 (4), e1-e36, 2020 | 1518 | 2020 |
| ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention … DE Griffith, T Aksamit, BA Brown-Elliott, A Catanzaro, C Daley, F Gordin, ... Am J Respir Crit Care Med 175 (4), 367-416, 2007 | 985 | 2007 |
| Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 HS Kuehn, W Ouyang, B Lo, EK Deenick, JE Niemela, DT Avery, ... Science 345 (6204), 1623-1627, 2014 | 947 | 2014 |
| Dominant-activating germline mutations in the gene encoding the PI (3) K catalytic subunit p110δ result in T cell senescence and human immunodeficiency CL Lucas, HS Kuehn, F Zhao, JE Niemela, EK Deenick, U Palendira, ... Nature immunology 15 (1), 88-97, 2014 | 811 | 2014 |
| Nontuberculous mycobacteria: I: multicenter prevalence study in cystic fibrosis KN Olivier, DJ Weber, RJ Wallace Jr, AR Faiz, JH Lee, Y Zhang, ... American journal of respiratory and critical care medicine 167 (6), 828-834, 2003 | 768 | 2003 |
| GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity MA Spinner, LA Sanchez, AP Hsu, PA Shaw, CS Zerbe, KR Calvo, ... Blood, The Journal of the American Society of Hematology 123 (6), 809-821, 2014 | 749 | 2014 |
| Prevalence of nontuberculous mycobacterial lung disease in US Medicare beneficiaries J Adjemian, KN Olivier, AE Seitz, SM Holland, DR Prevots American journal of respiratory and critical care medicine 185 (8), 881-886, 2012 | 742 | 2012 |
| Linezolid for treatment of chronic extensively drug-resistant tuberculosis M Lee, J Lee, MW Carroll, H Choi, S Min, T Song, LE Via, LC Goldfeder, ... New England Journal of Medicine 367 (16), 1508-1518, 2012 | 734 | 2012 |
| Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome AP Hsu, EP Sampaio, J Khan, KR Calvo, JE Lemieux, SY Patel, ... Blood, The Journal of the American Society of Hematology 118 (10), 2653-2655, 2011 | 703 | 2011 |
| Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems DR Prevots, PA Shaw, D Strickland, LA Jackson, MA Raebel, MA Blosky, ... American journal of respiratory and critical care medicine 182 (7), 970-976, 2010 | 659 | 2010 |
| US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis RA Floto, KN Olivier, L Saiman, CL Daley, JL Herrmann, JA Nick, ... Thorax 71 (Suppl 1), i1-i22, 2016 | 632 | 2016 |
| Adult-onset immunodeficiency in Thailand and Taiwan SK Browne, PD Burbelo, P Chetchotisakd, Y Suputtamongkol, ... New England Journal of Medicine 367 (8), 725-734, 2012 | 539 | 2012 |
| The association between sterilizing activity and drug distribution into tuberculosis lesions B Prideaux, LE Via, MD Zimmerman, S Eum, J Sarathy, P O'brien, C Chen, ... Nature medicine 21 (10), 1223-1227, 2015 | 505 | 2015 |
| Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome RD Kim, DE Greenberg, ME Ehrmantraut, SV Guide, L Ding, Y Shea, ... American journal of respiratory and critical care medicine 178 (10), 1066-1074, 2008 | 459 | 2008 |
| Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review AJ Shapiro, MA Zariwala, T Ferkol, SD Davis, SD Sagel, SD Dell, ... Pediatric pulmonology 51 (2), 115-132, 2016 | 453 | 2016 |
| Common severe infections in chronic granulomatous disease BE Marciano, C Spalding, A Fitzgerald, D Mann, T Brown, S Osgood, ... Clinical Infectious Diseases 60 (8), 1176-1183, 2015 | 425 | 2015 |
| Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry TR Aksamit, AE O’Donnell, A Barker, KN Olivier, KL Winthrop, ... Chest 151 (5), 982-992, 2017 | 418 | 2017 |
| Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity PA Flume, JD Chalmers, KN Olivier The Lancet 392 (10150), 880-890, 2018 | 411 | 2018 |
